It was unanimously agreed by the Reference Centre Directors that freeze-dried concentrates were the material of choice for home treatment. Read more about It was unanimously agreed by the Reference Centre Directors that freeze-dried concentrates were the material of choice for home treatment.
Professor Bloom became chairman of the Reference Centre Directors following Professor Blackburn's retirement. Read more about Professor Bloom became chairman of the Reference Centre Directors following Professor Blackburn's retirement.
It was decided that the General Meeting of Haemophilia Centre Directors would be in two parts: a business meeting followed by a scientific session. Read more about It was decided that the General Meeting of Haemophilia Centre Directors would be in two parts: a business meeting followed by a scientific session.
While presenting at a symposium held during the 3rd meeting of the European and African Division of the International Society of Haemtology, Dr Rizza stated that the Directors of UK haemophilia centres were "involved in a very active programme of research, including a review of the incidence of hepatitis and factor VIII antibodies in haemophiliacs, a trial of prophylactic treatment, and a survey of home therapy." Read more about While presenting at a symposium held during the 3rd meeting of the European and African Division of the International Society of Haemtology, Dr Rizza stated that the Directors of UK haemophilia centres were "involved in a very active programme of research, including a review of the incidence of hepatitis and factor VIII antibodies in haemophiliacs, a trial of prophylactic treatment, and a survey of home therapy."
In a Haemophilia Directors' meeting,13 September 1982, a US report was discussed which stated, among other things, that "there was a remote possibility that commercial blood products had been involved." Dr Ludlam in his oral evidence told to the Inquiry that he could not defend the word "remote". Read more about In a Haemophilia Directors' meeting,13 September 1982, a US report was discussed which stated, among other things, that "there was a remote possibility that commercial blood products had been involved." Dr Ludlam in his oral evidence told to the Inquiry that he could not defend the word "remote".
At a meeting of Haemophilia Centre Directors it was suggested that prophylactic and home treatment of Factor IX "to severely affected Christmas disease patients was beneficial. Regimes of weekly, fortnightly or even monthly administration had been tried with success". However, for the treatment of "classical" haemophilia (factor VIII deficiency), prophylactic and home therapy treatment "was more difficult". "It was felt that a controlled trial might be helpful. Read more about At a meeting of Haemophilia Centre Directors it was suggested that prophylactic and home treatment of Factor IX "to severely affected Christmas disease patients was beneficial. Regimes of weekly, fortnightly or even monthly administration had been tried with success". However, for the treatment of "classical" haemophilia (factor VIII deficiency), prophylactic and home therapy treatment "was more difficult". "It was felt that a controlled trial might be helpful.
Dr Obank from the DHSS attended the meeting of the Haemophilia Centre Directors where Dr Biggs delivered a short summary of a report on the incidence of jaundice. Read more about Dr Obank from the DHSS attended the meeting of the Haemophilia Centre Directors where Dr Biggs delivered a short summary of a report on the incidence of jaundice.
In a Health Circular, the DHSS set out the functions of the haemophilia reference centres. Read more about In a Health Circular, the DHSS set out the functions of the haemophilia reference centres.
A discussion was held between members of the DHSS and Dr Rosemary Biggs (representing the Oxford Haemophilia Centre) in relation to the organisation of haemophilia centres. Dr Biggs recommended the establishment of a three-tier system. Read more about A discussion was held between members of the DHSS and Dr Rosemary Biggs (representing the Oxford Haemophilia Centre) in relation to the organisation of haemophilia centres. Dr Biggs recommended the establishment of a three-tier system.
A NHS Memorandum was released stating that the listed haemophilia centres that had been "designated by the Medical Research Council for the diagnosis of haemophilia and related diseases" was going to be "revised" and going forward centres would be "described as Haemophilia Diagnostic and Registration Centres". Read more about A NHS Memorandum was released stating that the listed haemophilia centres that had been "designated by the Medical Research Council for the diagnosis of haemophilia and related diseases" was going to be "revised" and going forward centres would be "described as Haemophilia Diagnostic and Registration Centres".